Te Ahumairangi Investment Management Ltd Sells 2,050 Shares of Elevance Health, Inc. $ELV

Te Ahumairangi Investment Management Ltd decreased its position in Elevance Health, Inc. (NYSE:ELV) by 12.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 14,954 shares of the company’s stock after selling 2,050 shares during the period. Te Ahumairangi Investment Management Ltd’s holdings in Elevance Health were worth $5,242,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Rossby Financial LCC lifted its holdings in Elevance Health by 110.0% during the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after acquiring an additional 44 shares in the last quarter. J.Safra Asset Management Corp acquired a new stake in shares of Elevance Health during the fourth quarter worth about $32,000. ORG Partners LLC raised its position in shares of Elevance Health by 120.4% during the fourth quarter. ORG Partners LLC now owns 108 shares of the company’s stock worth $38,000 after purchasing an additional 59 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in shares of Elevance Health during the 4th quarter valued at about $38,000. Finally, Dorato Capital Management acquired a new position in shares of Elevance Health in the 4th quarter valued at approximately $41,000. Institutional investors own 89.24% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on ELV shares. Guggenheim increased their target price on Elevance Health from $396.00 to $399.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Robert W. Baird upped their price target on shares of Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a report on Thursday, April 23rd. Citigroup raised shares of Elevance Health to a “buy” rating in a research report on Wednesday, April 29th. Weiss Ratings upgraded shares of Elevance Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 18th. Finally, Truist Financial boosted their price objective on shares of Elevance Health from $375.00 to $450.00 and gave the company a “buy” rating in a research report on Monday, June 1st. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $416.11.

Elevance Health Trading Down 1.2%

NYSE ELV opened at $399.64 on Friday. Elevance Health, Inc. has a 52 week low of $273.71 and a 52 week high of $426.98. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48. The stock’s 50 day moving average price is $364.53 and its two-hundred day moving average price is $344.44. The stock has a market capitalization of $86.79 billion, a price-to-earnings ratio of 17.00, a PEG ratio of 2.29 and a beta of 0.67.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.74 by $1.84. The company had revenue of $49.49 billion for the quarter, compared to the consensus estimate of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. The firm’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company earned $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, analysts anticipate that Elevance Health, Inc. will post 26.93 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be paid a $1.72 dividend. This represents a $6.88 annualized dividend and a yield of 1.7%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s payout ratio is presently 29.26%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.